Table 2  Glucose concentrations for the IP-GTT group (mg/dL) ( a ), concurrent insulin concentrations (ng/mL) during an IP-GTT ( b ), and glucose concentrations during an IP-ITT ( c ) at 1 week of the study. Results at 16 weeks of the study for IP-GTT and IP-ITT for all groups are presented in Figs. 1 – 3 .

Group	0 min	15 min	30 min	45 min	60 min	120 min	AUC
a P < 0.05 temperature, b EPICAT, c time × temperature, d time × EPICAT, e time × EPICAT × temperature effects; † p < 0.08 time × temperature × EPICAT, three-way ANOVA, mean ± SEM, n = 8.
a Glucose concentrations for the IP-GTT group (mg/dL).
RT	85.4 ± 2.3	180.3 ± 6.5	125.8 ± 5.1	101.6 ± 2.7	102.1 ± 3.3	85.6 ± 2.9	3546.6 ± 283.2
TN	85.9 ± 1.7	206.9 ± 10.3	125.4 ± 4.6	92.5 ± 4.7	98.8 ± 4.3	85.2 ± 2.2	3615.0 ± 361.8
b IP-GTT concurrent insulin concentrations (ng/mL).
RT	0.671 ± 0.085	2.134 ± 0.268	1.161 ± 0.110	0.843 ± 0.099	0.682 ± 0.105	0.927 ± 0.099	45.8 ± 8.6
TN	0.611 ± 0.113	2.350 ± 0.360	1.170 ± 0.188	0.944 ± 0.194	0.844 ± 0.109	0.752 ± 0.102	62.1 ± 15.2
c IP-ITT glucose concentrations (mg/dL).
RT	88.2 ± 3.5	69.0 ± 2.6	51.7 ± 2.6	41.7 ± 2.3	40.8 ± 3.4	62.0 ± 5.1	4737.7 ± 511.7
TN	85.2 ± 2.5	64.4 ± 4.0	42.2 ± 2.4	36.2 ± 2.3	34.7 ± 2.0	61.7 ± 4.3	4936.4 ± 329.6